Figure 4.
The expression of WBSCR22 affected Caco-2 cell sensitivity to oxaliplatin. (A) Western blot analysis of WBSCR22 in Caco-2 cells transfected by Wbscr22 or vector constructs, respectively. (B) Proliferation study of the Caco-2-Wbscr22 and Caco-2-vector cells upon oxaliplatin treatment at the indicated concentration. The results were representative of three independent experiments and the results were expressed as the mean ± SD. (C) Western blot of WBSCR22 in the shCon or shRNA1 treated Caco-2 cells transfected by either Myc-DDK-WBSCR22 or vector constructs, respectively. (D) Cell proliferation of Caco-2 shRNA1-vector, shRNA1-Wbscr22, shCon-vector and shCon-Wbscr22 cells upon oxaliplatin treatment. The IC50 value of each cell line was indicated. The results were representative of three independent experiments and the results were expressed as the mean ± SD.